Blood cancer patient funding life extending drug

Prior to the election, Christopher Luxon made a commitment to fund a list of hard tumour cancer medications. At the same time National repeatedly promised that blood cancer sufferers would not be forgotten. But two years on from that promise, many of them do feel forgotten. The drug Daratumumab, or Dara is on Pharmac's priority drug list. That's the list of drugs it would like to fund, but can't afford. Dara is virtually free in Australia, but costs hundreds of thousand of dollars here. That means some desperate blood cancer patients are funding it themselves; relying on the kindness of others and donation pages. Aucklander Geoff Dawson, has multiple Myeloma, and is on Dara, he spoke to Lisa Owen.